Literature DB >> 30971781

Guidelines for using sigQC for systematic evaluation of gene signatures.

Andrew Dhawan1, Alessandro Barberis1, Wei-Chen Cheng1, Enric Domingo1, Catharine West2, Tim Maughan1, Jacob G Scott3, Adrian L Harris1, Francesca M Buffa4.   

Abstract

With the increased use of next-generation sequencing generating large amounts of genomic data, gene expression signatures are becoming critically important tools for the interpretation of these data, and are poised to have a substantial effect on diagnosis, management, and prognosis for a number of diseases. It is becoming crucial to establish whether the expression patterns and statistical properties of sets of genes, or gene signatures, are conserved across independent datasets. Conversely, it is necessary to compare established signatures on the same dataset to better understand how they capture different clinical or biological characteristics. Here we describe how to use sigQC, a tool that enables a streamlined, systematic approach for the evaluation of previously obtained gene signatures across multiple gene expression datasets. We implemented sigQC in an R package, making it accessible to users who have knowledge of file input/output and matrix manipulation in R and a moderate grasp of core statistical principles. SigQC has been adopted in basic biology and translational studies, including, but not limited to, the evaluation of multiple gene signatures for potential clinical use as cancer biomarkers. This protocol uses a previously obtained signature for breast cancer metastasis as an example to illustrate the critical quality control steps involved in evaluating its expression, variability, and structure in breast tumor RNA-sequencing data, a different dataset from that in which the signature was originally derived. We demonstrate how the outputs created from sigQC can be used for the evaluation of gene signatures on large-scale gene expression datasets.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30971781     DOI: 10.1038/s41596-019-0136-8

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  12 in total

1.  RadiationGeneSigDB: a database of oxic and hypoxic radiation response gene signatures and their utility in pre-clinical research.

Authors:  Venkata Sk Manem; Andrew Dhawan
Journal:  Br J Radiol       Date:  2019-09-25       Impact factor: 3.039

2.  Mitochondrial Inhibitor Atovaquone Increases Tumor Oxygenation and Inhibits Hypoxic Gene Expression in Patients with Non-Small Cell Lung Cancer.

Authors:  Michael Skwarski; Daniel R McGowan; Elizabeth Belcher; Francesco Di Chiara; Dionisios Stavroulias; Mark McCole; Jennifer L Derham; Kwun-Ye Chu; Eugene Teoh; Jagat Chauhan; Dawn O'Reilly; Benjamin H L Harris; Philip S Macklin; Joshua A Bull; Marcus Green; Gonzalo Rodriguez-Berriguete; Remko Prevo; Lisa K Folkes; Leticia Campo; Petra Ferencz; Paula L Croal; Helen Flight; Cathy Qi; Jane Holmes; James P B O'Connor; Fergus V Gleeson; W Gillies McKenna; Adrian L Harris; Daniel Bulte; Francesca M Buffa; Ruth E Macpherson; Geoff S Higgins
Journal:  Clin Cancer Res       Date:  2021-02-17       Impact factor: 12.531

3.  Protein structure-based gene expression signatures.

Authors:  Rayees Rahman; Nicole Zatorski; Jens Hansen; Yuguang Xiong; J G Coen van Hasselt; Eric A Sobie; Marc R Birtwistle; Evren U Azeloglu; Ravi Iyengar; Avner Schlessinger
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-11       Impact factor: 11.205

4.  Replication catastrophe induced by cyclic hypoxia leads to increased APOBEC3B activity.

Authors:  Samuel B Bader; Tiffany S Ma; Charlotte J Simpson; Jiachen Liang; Sakura Eri B Maezono; Monica M Olcina; Francesca M Buffa; Ester M Hammond
Journal:  Nucleic Acids Res       Date:  2021-07-21       Impact factor: 16.971

5.  Disruption of hypoxia-inducible fatty acid binding protein 7 induces beige fat-like differentiation and thermogenesis in breast cancer cells.

Authors:  Masahiro Kawashima; Karim Bensaad; Christos E Zois; Alessandro Barberis; Esther Bridges; Simon Wigfield; Christoffer Lagerholm; Ruslan I Dmitriev; Mariko Tokiwa; Masakazu Toi; Dmitri B Papkovsky; Francesca M Buffa; Adrian L Harris
Journal:  Cancer Metab       Date:  2020-07-06

6.  Role of gene signatures combined with pathology in classification of oropharynx head and neck cancer.

Authors:  Andrew Dhawan; Jacob Scott; Purnima Sundaresan; Michael Veness; Sandro Porceddu; Eric Hau; Adrian L Harris; Francesca M Buffa; Harriet E Gee
Journal:  Sci Rep       Date:  2020-06-23       Impact factor: 4.379

7.  Clonal selection confers distinct evolutionary trajectories in BRAF-driven cancers.

Authors:  Priyanka Gopal; Elif Irem Sarihan; Eui Kyu Chie; Gwendolyn Kuzmishin; Semihcan Doken; Nathan A Pennell; Daniel P Raymond; Sudish C Murthy; Usman Ahmad; Siva Raja; Francisco Almeida; Sonali Sethi; Thomas R Gildea; Craig D Peacock; Drew J Adams; Mohamed E Abazeed
Journal:  Nat Commun       Date:  2019-11-13       Impact factor: 14.919

Review 8.  Derivation and Application of Molecular Signatures to Prostate Cancer: Opportunities and Challenges.

Authors:  Dimitrios Doultsinos; Ian G Mills
Journal:  Cancers (Basel)       Date:  2021-01-28       Impact factor: 6.639

Review 9.  Epigenetic dysregulation of immune-related pathways in cancer: bioinformatics tools and visualization.

Authors:  Anders Berglund; Ryan M Putney; Imene Hamaidi; Sungjune Kim
Journal:  Exp Mol Med       Date:  2021-05-07       Impact factor: 12.153

10.  Radiosensitivity index emerges as a potential biomarker for combined radiotherapy and immunotherapy.

Authors:  Yang-Hong Dai; Ying-Fu Wang; Po-Chien Shen; Cheng-Hsiang Lo; Jen-Fu Yang; Chun-Shu Lin; Hsing-Lung Chao; Wen-Yen Huang
Journal:  NPJ Genom Med       Date:  2021-06-02       Impact factor: 8.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.